Zanzalintinib
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Zanzalintinib, covering 2025-06-12 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) [Phase 3]